On October 4, miRecule announced that it has entered into a strategic cooperation and exclusive license agreement with Sanofi to accelerate the development of “best-in-class”
On October 4, Pfizer announced that the oral PARP inhibitor Talzenna (talazoparib) combined with Xtandi (enzalutamide) in the treatment of male patients with metastatic castration-resistant
Transcriptome, proteome and metabolome, among these three omics, metabolome is considered to be the most difficult omics. Because of the many types of metabolites, the
Both mRNA vaccines and inactivated vaccines are autoimmune preparations made of bacteria, viruses and other pathogenic microorganisms and their metabolites through special preparation methods for
On October 3, Alexion, a subsidiary of AstraZeneca’s rare disease business, announced that it had reached a definitive acquisition agreement with Lexington. The acquisition is
On October 3, Incyte announced the acquisition of Villaris Therapeutics, which was invested and incubated by Medicxi, and acquired the latter’s anti-IL-15Rβ monoclonal antibody drug
On September 30, Intercept announced that the phase III REVERSE study of obeticholic acid (Ocaliva, obeticholic acid, OCA) in the treatment of nonalcoholic steatohepatitis (NASH)-related
On October 1, Taiho Oncology announced that the FDA has approved the marketing authorization application for the FGFR inhibitor futibatinib for the treatment of patients
Tumor immunology is a science that studies the relationship between tumor antigens, immune function of the body, and the occurrence, development and prognosis of tumors;
Recently, the FDA has rejected a number of products, one of which is a PDC drug that it has written in the past. In the
As an important component of current COVID-19 mRNA vaccines, lipid nanoparticles (LNPs) play a key role in effectively protecting mRNA and transporting it to cells.
Antibody drug conjugates (ADCs) are complex molecules in which monoclonal antibodies and cytotoxic drugs (small molecule payloads) are linked by linkers to form conjugates. In
